1-[1-butan-2-yl-6-[[2-(1-cyclopropylsulfonylpyrazol-4-yl)pyrimidin-4-yl]amino]imidazo[4,5-c]pyridin-2-yl]ethanol
C22H26N8O3S — CID 123927459
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[1-butan-2-yl-6-[[2-(1-cyclopropylsulfonylpyrazol-4-yl)pyrimidin-4-yl]amino]imidazo[4,5-c]pyridin-2-yl]ethanol
1-[1-butan-2-yl-6-[[2-(1-cyclopropylsulfonylpyrazol-4-yl)pyrimidin-4-yl]amino]imidazo[4,5-c]pyridin-2-yl]ethanol (PubChem CID 123927459) has the molecular formula C22H26N8O3S and a molecular weight of 482.57 g/mol. Its IUPAC name is 1-[1-butan-2-yl-6-[[2-(1-cyclopropylsulfonylpyrazol-4-yl)pyrimidin-4-yl]amino]imidazo[4,5-c]pyridin-2-yl]ethanol.
Molecular Properties
| Compound Name | 1-[1-butan-2-yl-6-[[2-(1-cyclopropylsulfonylpyrazol-4-yl)pyrimidin-4-yl]amino]imidazo[4,5-c]pyridin-2-yl]ethanol |
|---|---|
| PubChem CID | 123927459 |
| Molecular Formula | C22H26N8O3S |
| Molecular Weight | 482.57 g/mol |
| Exact Mass | 482.18 |
| IUPAC Name | 1-[1-butan-2-yl-6-[[2-(1-cyclopropylsulfonylpyrazol-4-yl)pyrimidin-4-yl]amino]imidazo[4,5-c]pyridin-2-yl]ethanol |
| SMILES | CCC(C)n1c(C(C)O)nc2cnc(Nc3ccnc(-c4cnn(S(=O)(=O)C5CC5)c4)n3)cc21 |
| InChI | InChI=1S/C22H26N8O3S/c1-4-13(2)30-18-9-20(24-11-17(18)26-22(30)14(3)31)27-19-7-8-23-21(28-19)15-10-25-29(12-15)34(32,33)16-5-6-16/h7-14,16,31H,4-6H2,1-3H3,(H,23,24,27,28) |
| InChIKey | KUZDHRSTKJRMBS-UHFFFAOYSA-N |
| XLogP | 3.19 |
| TPSA | 140.71 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 482.57 |
| LogP ≤ 5 | 3.19 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123927459 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.